Annual Membership

Inagene Advantage Membership

Pharmacogenetics is always advancing, and Inagene Advantage keeps you up to date. This annual membership helps you and your doctor make smarter medication choices by ensuring your personalized insights reflect the latest science.

Your membership includes:

  • Quarterly updates to your personalized insights as new medications are approved and research evolves
  • The ability to prioritize key medications so you can see their insights faster
  • A one-time 30-min consult with a pharmacist (Ontario residents only; rolling out to more provinces)

$125/year, billed annually and renews automatically.

Don't have a test yet? Add the membership to Complete Health, Pain & Mental Health or Women's Health and save $25 on your first year.

    Split your purchase into 3 monthly payments at check out

    Inagene Advantage Membership

    New Medications Added

    Pharmacogenetics is a rapidly advancing field, with ongoing discoveries revealing more medications influenced by genetics. Inagene Advantage keeps your personalized insights up to date with the latest advancements. As new medications and research findings become available, we ensure your results reflect the most current information—helping you and your doctor make confident, informed decisions.

    Science-Driven Precision

    As pharmacogenetic science evolves, new insights refine our understanding of how genes impact medications. This leads to more precise recommendations for both existing and new medications, always aligned with the latest high quality guidelines and data. With Inagene Advantage, your results remain comprehensive and up to date, helping you and your doctor make smarter, more informed health decisions.

    Don’t Have an Inagene Test Yet?

    Complete Health Test + Inagene Advantage Membership

    Bundle your test with the Inagene Advantage Membership and save $25 on your first year.

    Start your journey toward better health today.

    FAQ

    What is the Inagene Advantage Membership?

    The Inagene Advantage Membership is a subscription service that ensures your pharmacogenetic report stays up to date with the latest scientific discoveries. It provides regular updates on new medications and refined recommendations tailored to your genetics. Members also get a one-time 30-min consult with a pharmacist (Ontario residents only; rolling out to more provinces).

    Who can access the benefits of an Inagene Advantage Membership?

    An active membership entitles one individual access to updates for their own personal results. This means if you have multiple results for multiple individuals within your account, your updates apply to one of your choice.

    Why do I need this membership if I’ve already taken the test?

    The Inagene Advantage membership ensures your report stays current with advancements in pharmacogenetics, including newly added medications and more precise recommendations tailored to your genes. Without the membership, your report will remain accurate based on the science available when it was created but won’t include future updates or discoveries that could enhance your treatment decisions.

    How often is my report updated?

    Your report will be updated quarterly to reflect advancements in pharmacogenetics. Updates are driven by new scientific discoveries and ongoing research in this rapidly evolving field. As new insights and medications influenced by genetics are identified, we ensure your report stays current to provide you with the most accurate and up-to-date information.

    How do I book my pharmacist consult?

    Once your results are ready, log in to your secure online portal and click “Request a Consultation” on your report. We’ll email you a link to book a time. Available to Ontario residents; rolling out to more provinces.

    How do I access my updated report?

    You can access your updated report through your secure online portal. We’ll notify you via email each time your report is updated.

    Is the membership tailored to my genes?

    Yes. Your updates are personalized based on your genetic profile, ensuring the recommendations remain specific to you and your unique health journey.

    Can I get the membership if I haven’t taken an Inagene test yet?

    The Inagene Advantage Membership is available with our Complete Health, Pain & Mental Health and Women’s Health test. If you’ve already taken any of these tests, you can add the membership above. If not, bundle the test and membership to save.

    Shop Complete Health

    Shop Women's Health

    Shop Pain & Mental Health

    How do I cancel my membership?

    Your membership is billed annually and renews automatically. If you’d like to cancel, simply click here to manage your subscription.

    Why can’t I purchase the membership with the Cardiovascular Health test?

    Currently, the Inagene Advantage Membership is available with the Complete Health, Pain & Mental Health and Women’s Health test. To purchase a membership, add it above. If you’d like to upgrade your existing Cardiovascular Health test to Complete Health and sign up for the membership, please contact us at customerservice@inagene.com. If you are interested in a membership with this product, please let us know so we can better support your needs.

    Why are updates no longer complimentary, and why was a membership introduced?

    Pharmacogenetic research is evolving rapidly, with more gene-drug associations and new insights being discovered regularly. To better serve our customers and ensure they receive the most up-to-date information, we’ve introduced a membership that supports more frequent updates and includes a complimentary re-swab when we improve our test to analyze additional genes. While updates are no longer complimentary, this change allows us better support our customers and to provide the most accurate and reliable insights as the science continues to advance.

    • References

    • 1. Swen JJ, van der Wouden CH, Manson LE, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401(10374):347-356. doi:10.1016/S0140-6736(22)01841-4